ArticleNeuro-oncology2023

Recovery from the damage of cranial radiation modulated by memantine, an NMDA receptor antagonist, combined with hyperbaric oxygen therapy.

Yohei Hokama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.